PEGylated Hyaluronic Acid-Modified Liposomal Delivery System with Anti-γ-Glutamylcyclotransferase siRNA for Drug-Resistant MCF-7 Breast Cancer Therapy-Reference-Cited by-同舟云学术

PEGylated Hyaluronic Acid-Modified Liposomal Delivery System with Anti-γ-Glutamylcyclotransferase siRNA for Drug-Resistant MCF-7 Breast Cancer Therapy

Published:2015-02 Issue:2 Volume:104 Page:476-484
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Ran Rui,Liu Yayuan,Gao Huile,Kuang Qifang,Zhang Qianyu,Tang Jie,Fu Han,Zhang Zhirong,He Qin

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference31 articles.

1. A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma;Kageyama;Proteomics Clin Appl,2007

2. The identification and structural characterization of C7orf24 as (γ-glutamyl cyclotransferase an essential enzyme in the (γ-glutamyl cycle;Oakley;J Biol Chem,2008

3. Profiling alternatively spliced mRNA isoforms for prostate cancer classification;Zhang;BMC Bioinformatics,2006

4. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker;Gromov;J Proteome Res,2010

5. Localization and characterization of gamma-glutamyl cyclotransferase in cancer cells;Azumi;Mol Med Rep,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision arrows: Navigating breast cancer with nanotechnology siRNA;International Journal of Pharmaceutics;2024-09

2. Machine learning-based cell death marker for predicting prognosis and identifying tumor immune microenvironment in prostate cancer;Heliyon;2024-09

3. Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance;Nanomedicine;2023-11-15

4. Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy;Environmental Research;2023-11

5. Charge‐Reversible Nanoparticles: Advanced Delivery Systems for Therapy and Diagnosis;Small;2023-09-07